ArticleEClinicalMedicine2022

Immunogenicity and safety of an enterovirus 71 vaccine in children aged 36-71 months: A double-blind, randomised, similar vaccine-controlled, non-inferiority phase III trial.

Yeqing Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.